Device Trial Radar · NCT06952816
Automated Oxygen Titration With the EMILY.AI Device in a Respiratory Intermediate Care Unit
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
80
Planned (sponsor's estimate)
Start
Apr 15, 2025
Primary completion
Mar 30, 2027
Study completion Mar 30, 2027
Sponsor
- Lead sponsor
- Aether Tech S.L.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Hospital Universitario Fundación Jiménez Díaz
- First posted
- May 1, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates EMILY.AI, an investigational (non-CE-marked) smart oxygen valve that automatically adjusts the oxygen flow delivered to a patient. Adults with acute respiratory failure admitted to the Respiratory Intermediate Care Unit (RICU) of Hospital Universitario Fundación Jiménez Díaz (Madrid, Spain) receive oxygen titrated automatically by EMILY.AI and, in the same monitoring session, oxygen titrated manually by the nursing team while the device records saturation and flow. The study measures how much of the time patients stay within their target saturation range under each method, how fast the device corrects deviations, the alerts it generates, nursing workload, oxygen use and patient comfort. This substudy is part of clinical investigation FJD-EMILY-23-02, whose other substudies are registered in separate records.
Conditions
- Chronic Respiratory Failure
- Acute Respiratory Failure
- Hypoxemic Respiratory Failure
- Hypercapnic Respiratory Failure
- Acute-on-chronic Respiratory Failure
Interventions
Emily.AIDevice
Investigational smart oxygen valve with a rule-based algorithm that adjusts oxygen flow to keep SpO2 within a target range. Other names: EMILY.AI Smart Valve
Manual oxygen titrationOther
Standard care: oxygen flow set and adjusted by the unit's nursing team according to usual practice. The EMILY.AI device stays connected and records signals and flow but does not control delivery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- EFFICACY - EVALUATION OF THE RATE THE DEVICE MAINTAINS BLOOD OXYGEN SATURATION LEVELSTime frame: During the monitoring session: approximately 5 hours of closed-loop titration followed by approximately 5 hours of manual titration on the same day (closed-loop period only in the initial phase).
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.